BC Advantage Funds

BC Advantage Funds was a venture capital firm based in British Columbia, specializing in investments in early-stage life science, technology, and clean technology companies. Founded in 2003, the firm gained recognition for its strong performance, notably receiving the Canadian Venture Capital Association 'Deal of the Year' award in 2006 for achieving a remarkable 23.4X return on its investment in Aspreva Pharmaceuticals. Additionally, its Advantage Life Science Fund I delivered the highest five-year returns of any retail fund in Canada from 2006 to 2008. However, following the financial crisis of 2008-2009, the firm faced significant challenges in growing and financing its portfolio companies. In July 2016, the Board of Directors determined that the best course of action for maximizing shareholder value was to liquidate and dissolve the company. A special meeting of shareholders was held to approve this decision, leading to the distribution of the company’s remaining assets to shareholders.

Frank Holler

CEO and Partner

16 past transactions

Redlen Technologies

Venture Round in 2014
Redlen Technologies Inc. specializes in manufacturing cadmium zinc telluride (CZT) semiconductors, which are essential for radiation detection and imaging equipment used in various applications such as nuclear cardiology, CT scanning, baggage scanning, and bomb detection. Founded in 1999 and based in Saanichton, Canada, the company has pioneered a unique production process known as the Traveling Heater Method (THM) to create advanced CZT semiconductor wafers. This innovation enhances the performance, cost-efficiency, and availability of radiation detection technologies, facilitating their adoption in both medical and security sectors. Additionally, Redlen provides high-purity cadmium telluride feedstock solutions for thin film solar photovoltaic applications, thereby contributing to the renewable energy market. With a strong focus on advancing semiconductor and imaging technology, Redlen Technologies is positioned as a leader in high-performance detection solutions.

Microvisk Technologies

Venture Round in 2010
MicroVisk Limited, founded in 2004 and based in Oxford, United Kingdom, specializes in the development of innovative medical devices. The company has created CoagMax, a point-of-care monitor that enables patients to conduct PT/INR testing at home, facilitating self-monitoring of blood coagulation levels. This device utilizes advanced micro electro mechanical sensors embedded in a disposable smart strip, allowing for a convenient, safe, and accurate testing experience. By focusing on patient-friendly solutions, MicroVisk aims to improve the quality of life for individuals requiring regular blood coagulation monitoring.

Aquinox Pharmaceuticals

Series B in 2010
Aquinox Pharmaceuticals Inc., a pharmaceutical company, engages in discovery, development, and commercialization of small molecule therapeutics for the treatment of cancer and inflammatory disease. It offers AQX-MN100, a drug used to treat cancer and inflammatory disease, as well as SH2-containing inositol 5'-phosphatase inhibition program for blood cell recovery. The company was founded in 2004 and is based in Vancouver, Canada.

Redlen Technologies

Venture Round in 2010
Redlen Technologies Inc. specializes in manufacturing cadmium zinc telluride (CZT) semiconductors, which are essential for radiation detection and imaging equipment used in various applications such as nuclear cardiology, CT scanning, baggage scanning, and bomb detection. Founded in 1999 and based in Saanichton, Canada, the company has pioneered a unique production process known as the Traveling Heater Method (THM) to create advanced CZT semiconductor wafers. This innovation enhances the performance, cost-efficiency, and availability of radiation detection technologies, facilitating their adoption in both medical and security sectors. Additionally, Redlen provides high-purity cadmium telluride feedstock solutions for thin film solar photovoltaic applications, thereby contributing to the renewable energy market. With a strong focus on advancing semiconductor and imaging technology, Redlen Technologies is positioned as a leader in high-performance detection solutions.

Microvisk Technologies

Venture Round in 2010
MicroVisk Limited, founded in 2004 and based in Oxford, United Kingdom, specializes in the development of innovative medical devices. The company has created CoagMax, a point-of-care monitor that enables patients to conduct PT/INR testing at home, facilitating self-monitoring of blood coagulation levels. This device utilizes advanced micro electro mechanical sensors embedded in a disposable smart strip, allowing for a convenient, safe, and accurate testing experience. By focusing on patient-friendly solutions, MicroVisk aims to improve the quality of life for individuals requiring regular blood coagulation monitoring.

Zeugma Systems

Series C in 2009
Zeugma Systems is a privately held company that specializes in telecommunications equipment and applications for broadband service providers. The company offers the Zeugma Services Node, a service delivery router that consolidates extensive computing resources with advanced capacity and awareness of both services and subscribers in a robust, fully redundant system. This innovative equipment enables service providers to swiftly prototype and launch new revenue-generating services, monitor session flows at a granular level, and manage individual session flows to enforce quality of service policies. Additionally, Zeugma Systems provides Zeugma OSS for configuration and health management of their systems, and Smart Series Applications, which enhance various services like video on demand and voice over IP. Their solutions also support usage-based billing frameworks, reducing the need for multiple edge devices while facilitating standard broadband aggregation and subscriber management functions.

Inimex Pharmaceuticals

Series B in 2008
Inimex Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in Burnaby, Canada, specializing in the development and commercialization of Innate Defense Regulators (IDRs). These innovative drugs are designed to selectively modulate the body's innate immune defenses without inducing inflammation. The company's lead product, IMX942, aims to enhance survival rates, reduce tissue damage, and mitigate bacterial infections. Inimex's IDR products target a range of medical conditions, including infections and tissue injury-related ailments such as ventilator-associated pneumonia, tracheobronchitis, bacteremia, endocarditis, mucositis, and certain cancers. Founded in 2001, Inimex Pharmaceuticals is dedicated to advancing its unique therapies to improve patient outcomes.

NPS

Venture Round in 2008
NPS was founded in November 2003 in order to exploit polymer technology invented and developed by UK Government research laboratories. Having established an exclusive licence to the technology, NPS has been working to apply it to specific applications across many industries.

Mobidia Technology

Venture Round in 2008
Mobidia Technology, Inc. specializes in mobile app and network usage data solutions, offering insights that help businesses track competitors and optimize their services. Founded in 2004 and based in Richmond, Canada, the company provides a comprehensive analytics platform that delivers real usage data worldwide. By analyzing trends in mobile and Wi-Fi data, Mobidia enables companies to enhance their advertising strategies, refine data plans, and improve over-the-top service offerings. The firm's popular My Data Manager application assists smartphone users in managing their data consumption, leading to cost savings on mobile plans while also supporting mobile operators in increasing revenue and reducing operational costs. As of 2015, Mobidia operates as a subsidiary of App Annie Limited.

Zeugma Systems

Series B in 2007
Zeugma Systems is a privately held company that specializes in telecommunications equipment and applications for broadband service providers. The company offers the Zeugma Services Node, a service delivery router that consolidates extensive computing resources with advanced capacity and awareness of both services and subscribers in a robust, fully redundant system. This innovative equipment enables service providers to swiftly prototype and launch new revenue-generating services, monitor session flows at a granular level, and manage individual session flows to enforce quality of service policies. Additionally, Zeugma Systems provides Zeugma OSS for configuration and health management of their systems, and Smart Series Applications, which enhance various services like video on demand and voice over IP. Their solutions also support usage-based billing frameworks, reducing the need for multiple edge devices while facilitating standard broadband aggregation and subscriber management functions.

Aquinox Pharmaceuticals

Series A in 2007
Aquinox Pharmaceuticals Inc., a pharmaceutical company, engages in discovery, development, and commercialization of small molecule therapeutics for the treatment of cancer and inflammatory disease. It offers AQX-MN100, a drug used to treat cancer and inflammatory disease, as well as SH2-containing inositol 5'-phosphatase inhibition program for blood cell recovery. The company was founded in 2004 and is based in Vancouver, Canada.

Contigo Systems

Series B in 2007
Contigo Systems Inc. specializes in developing and managing a location-based services platform designed for businesses to effectively monitor vehicles, assets, and personnel via the Internet. The company offers solutions such as RideAlong, a GPS tracking system tailored for fleet and asset management, as well as lone worker safety applications. These products are particularly beneficial for organizations with mobile workers operating alone or in challenging environments, providing compliance with safety regulations and enhancing worker security. Contigo's offerings are distributed through a network of value-added resellers, major wireless carriers, and enterprise customers primarily in the United States and Canada. Founded in 2002 and headquartered in Vancouver, Canada, with an additional office in Santa Monica, California, Contigo Systems was previously known as Guardian Mobile Monitoring Systems, Inc. The company operates as a subsidiary of Vecima Networks Inc. since 2016.

Mobidia Technology

Series A in 2007
Mobidia Technology, Inc. specializes in mobile app and network usage data solutions, offering insights that help businesses track competitors and optimize their services. Founded in 2004 and based in Richmond, Canada, the company provides a comprehensive analytics platform that delivers real usage data worldwide. By analyzing trends in mobile and Wi-Fi data, Mobidia enables companies to enhance their advertising strategies, refine data plans, and improve over-the-top service offerings. The firm's popular My Data Manager application assists smartphone users in managing their data consumption, leading to cost savings on mobile plans while also supporting mobile operators in increasing revenue and reducing operational costs. As of 2015, Mobidia operates as a subsidiary of App Annie Limited.

Metrobridge

Series B in 2005
MetroBridge Networks Corporation is a privately held company that specializes in delivering broadband wireless access through advanced technologies. The company operates a redundant microwave network capable of providing internet connections of up to 100 Mbps across its coverage area and up to 1 Gbps in urban centers. Formed from the merger of two leading broadband wireless providers, Universco and AirCelerator, MetroBridge focuses on serving a diverse clientele, including stand-alone businesses, multi-tenant commercial customers, and temporary locations such as construction sites and film productions. Earlier this year, MetroBridge achieved recognition as the first Canadian broadband wireless access provider to be accepted into the WiMAX Forum, underscoring its commitment to innovation in the wireless broadband industry.

Mobidia Technology

Series A in 2005
Mobidia Technology, Inc. specializes in mobile app and network usage data solutions, offering insights that help businesses track competitors and optimize their services. Founded in 2004 and based in Richmond, Canada, the company provides a comprehensive analytics platform that delivers real usage data worldwide. By analyzing trends in mobile and Wi-Fi data, Mobidia enables companies to enhance their advertising strategies, refine data plans, and improve over-the-top service offerings. The firm's popular My Data Manager application assists smartphone users in managing their data consumption, leading to cost savings on mobile plans while also supporting mobile operators in increasing revenue and reducing operational costs. As of 2015, Mobidia operates as a subsidiary of App Annie Limited.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.